While reporting financial results for the first quarter on Thursday, drugmaker Eli Lilly and Co. (LLY) lowered its earnings and adjusted earnings guidance for the full-year 2025, while maintaining annual revenue outlook.
For fiscal 2025, Eli Lilly now projects earnings in a range of $20.17 to $21.67 per share and adjusted earnings in a range of $20.78 to $22.28 per share on revenues between $58.0 billion and $61.0 billion.
Previously, the company expected earnings in a range of $22.05 to $23.55 per share and adjusted earnings in a range of $22.50 to $24.00 per share on revenues between $58.0 billion and $61.0 billion.
On average, analysts polled expect the company to report earnings of $22.40 per share on revenues of $59.57 billion for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.